AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Valar Labs, Inc. announced it raised $4.15 Million in an initial filing from an offering of $4.15 Million

Apr 04, 2022•over 3 years ago

Amount Raised

$4.15 Million

Round Type

seed

Palo AltoBiotechnology

Company Information

Company

Valar Labs, Inc.

Location

1885 El Camino Real, 2nd Floor

Palo Alto, California, United States

About

Valar Labs is a precision medicine company developing computational histology AI tests for predicting response to cancer therapies. Our goal is to provide every patient and physician the ability to select the best treatment based on the patient's tumor biology. Our bladder cancer test, Vesta, predicts which patients are unlikely to benefit from BCG therapy and provides detailed risk stratification for recurrence and progression. Vesta is clinically available through our CLIA-certified laboratory in Houston, Texas and can be ordered online.

Company News

(2 articles)

Thu, 30 May 2024 07:00:00 GMT

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M - TechCrunch

Wed, 01 May 2024 07:00:00 GMT

Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer - Business Wire

FundzWatch™ Score

Medium Activity